Although RF predicts TIMP3, INMT and SLC16A1 followed by ALPL as the important feature genes in subtype 3, the expressions of these three genes are not consistently lower or higher than all other subtypes of meningioma, which restricts their potent of being biomarkers for meningioma. The gene discussed is TIMP3; the disease is meningioma.